TA
CMD

Tamarack Advisers’s Cantel Medical Corporation CMD Stock Holding History

Tamarack Advisers’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-135,000
Closed -$10.1M – 35
2019
Q3 		$10.1M Buy
135,000
+20,000
+17% +$1.7M 2.63% 13
2019
Q2 		$9.11M Buy
115,000
+85,000
+283% +$5.98M 2.77% 15
2019
Q1 		$2.01M Buy
+30,000
New +$2.27M 0.8% 19

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Tamarack Advisers's CMD Position: Q4 2019 in Review

Tamarack Advisers sold out of Cantel Medical Corporation (CMD) in Q4 2019, closing a stake of 135,000 shares — an estimated $10.1M sold.

Tamarack Advisers first reported a position in CMD in Q1 2019 and held it in 3 quarters. The position peaked at $10.1M in Q3 2019. 237 funds tracked by Wall St. Rank hold CMD as of Q4 2019.

  • Tamarack Advisers reported no remaining Cantel Medical Corporation position as of Q4 2019 after selling out during the quarter.
  • Tamarack Advisers sold 135,000 Cantel Medical Corporation shares in Q4 2019, an estimated $10.1M.
  • Tamarack Advisers first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 3 quarters.
  • Tamarack Advisers's Cantel Medical Corporation position peaked at $10.1M in Q3 2019.
  • 237 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2019.

Based on Tamarack Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.